Tim Jobson, medical director of Predictive Health Intelligence says: “It’s time to end the late diagnosis of liver disease, which places a huge burden on the health of the nation and which accounts for 26,000 premature deaths and 100,000 years of lost life each year. Combining precision medicine with proven technologies has the potential to pave the way for national screening and risk-stratification for liver and metabolic disease. This cannot come soon enough.”

Louise Campbell, founder and clinical director of Tawazun Health, says: “This is an important and urgently needed project. The majority of patients with liver disease are diagnosed too late for effective intervention or treatment, so improving early detection – through this joined-up, non-invasive approach – is critical. We’re pleased to be assisting with the delivery of Fibroscanning services enabling a greater level of consistency and efficiency.”

About the grant co-applicants:
Sano Genetics helps precision medicine clinical operations teams accelerate trials by combining at-home genetic testing, recruitment, and long-term patient engagement all in one place, for faster enrollment and simplified operations. It can find hard-to-reach patients 10x faster at 5x lower cost. https://sponsors.sanogenetics.com

Predictive Health Intelligence, a pioneering partnership between NHS leaders, healthcare information management, and clinical experts, has developed a case-finding search engine that uses existing data to make identifying patients at risk of liver disease straightforward and cost-effective. https://predictivehealthintelligence.co.uk

Somerset NHS Foundation Trust delivers acute, mental health and community services across Somerset. https://www.somersetft.nhs.uk

Back to HCB News

Business Affairs Homepage